Nuance Pharma ("Nuance") today announces its top-line Phase 3 ENHANCE-CHINA (NCT05743075) trial results evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary ...

In the latest research into early antibiotic exposure and development of childhood conditions, a study of infants born ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by ...

Thank you for standing by and welcome to the LeddarTech Second Quarter 2025 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. There will not be a ...

Fifi Box was unable to contain her emotion on Wednesday after receiving an emotional update about Underdogs star Elijah.

"Further research into the biologic factors, clinical implications, and interventions targeting this aspect of COPD is ...

The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...

What is the current share price of APA Group (APA)? APA Group's (APA) current share price is $8.23. This constitutes a price movement of 0% when compared to the share price 7 days ago and is -6.90% ...

What is the current share price of Endeavour Group Limited (EDV)? Endeavour Group Limited's (EDV) current share price is $4.16. This constitutes a price movement of 3.74% when compared to the share ...

Younger generations are also more likely to express concern. Except for the Silent Generation, at least half of every age group—including baby boomers, Gen X, millennials, and Gen Z—see Trump ...

Between-group differences in measures of health-related ... The change from baseline to week 52 in the prebronchodilator FEV 1 was assessed as an exploratory efficacy end point.